RxDoctor Payments Data

David Lafferty

Otolaryngology · Newark, DENPI 1063952463

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $6,040 of the $9,259 with a category attached, or 65.2%. 18 manufacturers reported payments, led by Cochlear Americas at 28.4% of the total. Reporting peaked in 2024 at $4,414 and has fallen 51.2% since, to $2,155 in 2025. Among otolaryngology clinicians in DE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$9,259in general payments, 2019–2025

Across 126 payments — averaging $73.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cochlear Americas$3K
  • Med-el Corporation$1K
  • Acclarent, Inc$1K
  • Sanofi$617
  • Integra Lifesciences Corporation$598
  • Medtronic$426
  • plus $2K from 12 others

What the payments were for

  • Travel & lodging$3,21935%
  • Food & beverage$6,04065%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$9,259 in reported general payments places this provider in the 95th percentile of 27 otolaryngology providers in Delaware.

See all otolaryngology providers in Delaware

Medicare billing

Part B allowed, 2024
$71,694
Medicare patients
149
Services billed
791

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth45$7,454
Nortriptyline Hcl108$3,390
Ipratropium Bromide21$1,088
Ofloxacin36$1,072
Prednisolone Acetate11$539
Propranolol Hcl ErPropranolol Hcl11$512
Omeprazole28$453
Betamethasone Dipropionate17$414
Pantoprazole Sodium11$284
Famotidine22$227
Fluticasone Propionate23$210
Topiramate20$178
Azelastine Hcl13$164
RizatriptanRizatriptan Benzoate12$156
Prednisone32$125

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Newark

See the full list for Delaware

Where these figures come from

Is this you, or does something look wrong? →